BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 26404408)

  • 1. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W; Shi WK; Wang PF; Zeng XT; Li P; Zhang JR; Li Q; Tang ZP; Peng J; Wu LZ; Xie MQ; Liu C; Li XH; Wang YC; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2015 Oct; 23(20):6602-11. PubMed ID: 26404408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W; Liu Q; Li ZZ; Shi WK; Fu X; Liu J; Zhu X; Wang XC; Xu N; Li TF; Jiang FR; Xiao ZP; Zhu HL
    Eur J Med Chem; 2017 Jun; 133():62-68. PubMed ID: 28380394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP; Wei W; Wang PF; Shi WK; Zhu N; Xie MQ; Sun YW; Li LX; Xie YX; Zhu LS; Tang N; Ouyang H; Li XH; Wang GC; Zhu HL
    Eur J Med Chem; 2015 Sep; 102():631-8. PubMed ID: 26318069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP; Ma TW; Liao ML; Feng YT; Peng XC; Li JL; Li ZP; Wu Y; Luo Q; Deng Y; Liang X; Zhu HL
    Eur J Med Chem; 2011 Oct; 46(10):4904-14. PubMed ID: 21856050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP; Ouyang H; Wang XD; Lv PC; Huang ZJ; Yu SR; Yi TF; Yang YL; Zhu HL
    Bioorg Med Chem; 2011 Jul; 19(13):3884-91. PubMed ID: 21669535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD; Deng RC; Dong JJ; Peng ZY; Gao XM; Li ST; Lin WQ; Lu CL; Xiao ZP; Zhu HL
    Bioorg Med Chem; 2013 Sep; 21(17):4914-22. PubMed ID: 23891164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW; Wang PF; Tang DJ; Tao XX; Man RJ; Qiu HY; Wang ZC; Xu C; Zhu HL
    Chem Biol Drug Des; 2016 Oct; 88(4):592-8. PubMed ID: 27206529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel dinitrobenzotrifluoride containing o-hydroxybenzylamine derivatives as potential antibacterial agents.
    Li QS; Ni HJ; Yang Y; Lv XH; Ruan BF
    Med Chem; 2015; 11(3):305-13. PubMed ID: 25219926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM; Gad-Elkareem MAM; Hassane Anouar E; Aouadi K; Kadri A; Snoussi M
    Bioorg Chem; 2020 Sep; 102():104105. PubMed ID: 32717689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenyltriazole-functionalized sulfamate inhibitors targeting tyrosyl- or isoleucyl-tRNA synthetase.
    De Ruysscher D; Pang L; Mattelaer CA; Nautiyal M; De Graef S; Rozenski J; Strelkov SV; Lescrinier E; Weeks SD; Van Aerschot A
    Bioorg Med Chem; 2020 Aug; 28(15):115580. PubMed ID: 32631562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Compounds as Inhibitors of Tyrosyl-tRNA Synthetase.
    Skupińska M; Stępniak P; Łętowska I; Rychlewski L; Barciszewska M; Barciszewski J; Giel-Pietraszuk M
    Microb Drug Resist; 2017 Apr; 23(3):308-320. PubMed ID: 27487455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
    Guo ZH; Yin Y; Wang C; Wang PF; Zhang XT; Wang ZC; Zhu HL
    Bioorg Med Chem; 2015 Sep; 23(18):6148-56. PubMed ID: 26304108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triaminotriazine DNA helicase inhibitors with antibacterial activity.
    McKay GA; Reddy R; Arhin F; Belley A; Lehoux D; Moeck G; Sarmiento I; Parr TR; Gros P; Pelletier J; Far AR
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1286-90. PubMed ID: 16343901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.
    Xiao ZP; He XB; Peng ZY; Xiong TJ; Peng J; Chen LH; Zhu HL
    Bioorg Med Chem; 2011 Mar; 19(5):1571-9. PubMed ID: 21330140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J; Lv PC; Zhu HL
    Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and antibacterial activities of 5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol derivatives containing Schiff base formation as FabH inhibitory.
    Zhang F; Wen Q; Wang SF; Shahla Karim B; Yang YS; Liu JJ; Zhang WM; Zhu HL
    Bioorg Med Chem Lett; 2014 Jan; 24(1):90-5. PubMed ID: 24332628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF; Yin Y; Qiao F; Wu X; Sha S; Zhang L; Zhu HL
    Bioorg Med Chem; 2014 Apr; 22(8):2409-15. PubMed ID: 24680059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitors of bacterial tyrosyl tRNA synthetase: synthesis of carbocyclic analogues of the natural product SB-219383.
    Jarvest RL; Berge JM; Houge-Frydrych CS; Mensah LM; O'Hanlon PJ; Pope AJ
    Bioorg Med Chem Lett; 2001 Sep; 11(18):2499-502. PubMed ID: 11549455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and activity of analogues of SB-219383: novel potent inhibitors of bacterial tyrosyl tRNA synthetase.
    Berge JM; Broom NJ; Houge-Frydrych CS; Jarvest RL; Mensah L; McNair DJ; O'Hanlon PJ; Pope AJ; Rittenhouse S
    J Antibiot (Tokyo); 2000 Nov; 53(11):1282-92. PubMed ID: 11213289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and evaluation of second generation MurF inhibitors based on a cyanothiophene scaffold.
    Hrast M; Anderluh M; Knez D; Randall CP; Barreteau H; O'Neill AJ; Blanot D; Gobec S
    Eur J Med Chem; 2014 Feb; 73():83-96. PubMed ID: 24384549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.